A University of Alberta research team has identified a new drug target to treat harmful E. coli bacteria—which cause nearly 250,000 deaths a year from urinary tract infections (UTI) and are becoming ...
Pivya ® (pivmecillinam tablets) is now available for the treatment of female patients aged 18 years and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results